Effect of intravitreal injections and volume changes on intraocular pressure: Clinical results and biomechanical model

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 7, 2007, Pages 777-781

  Kotliar, Konstantin ^a   Maier, Mathias ^a   Bauer, Svetlana ^b   Feucht, Nikolaus ^a   Lohmann, Chris ^a   Lanzl, Ines ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Biomechanical model; Intraocular pressure; Intravitreal injection; Triamcinolone

Indexed keywords

SODIUM CHLORIDE; TRIAMCINOLONE;

AGED; ARTICLE; BIOMECHANICS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG INJECTION VOLUME; EYE AXIS LENGTH; FEMALE; HUMAN; HYPERMETROPIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MATHEMATICAL MODEL; MYOPIA; OCULOPLETHYSMOGRAPHY; PARACENTESIS; PRIORITY JOURNAL; RETINA DISEASE;

AGED; BIOMECHANICS; EYE; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MODELS, BIOLOGICAL; PARACENTESIS; TONOMETRY, OCULAR; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 35448934930     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00939.x     Document Type: Article

References (23)

1. Atanatzkovich T & Guran A (2003): Lectures on Theory of Elasticity. St. Petersburg: State University Press SPbSU 392.
2. Battaglioli JL & Kamm RD (1984): Measurements of the compressive properties of scleral tissue. Invest Ophthalmol Vis Sci 25: 59-65.
3. Bauer SM, Zimin BA & Tovstik PE (2000): The Simplest Analytical Models of Shells and Plates in Ophthalmology. St. Petersburg: State University Press 92.
4. Brubaker RF (1998): Clinical measurements of aqueous humour dynamics: implications for addressing glaucoma. In: Civan MM (ed). The Eye's Aqueous Humor: From Secretion to Glaucoma. San Diego: Academic Press 234-284.
5. Cioffi GAE, Granstam & Alm (2003): Ocular circulation. In: Kaufmann PL (ed). Adler's Physiology of the Eye. St. Louis, London: Mosby 747-784.
6. Danis RP, Ciulla TA, Pratt LM & Anliker W (2000): Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-250.
7. Eisenlohr JE, Langham ME & Maumenee AE (1962): Manometric studies of the pressure-volume relationship in living and enucleated eyes of individual human subjects. Br J Ophthalmol 46: 536-548.
8. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M Jr & Guyer DR (2004): Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 2805-2816.
9. Hayreh SS & Jonas JB (2000): Optic disc and retinal nerve fibre layer damage after transient central retinal artery occlusion: An experimental study in rhesus monkeys. Am J Ophthalmol 129: 786-795.
10. Heatley CJ, Lim KS, Siriwardena D & Barton K (2006): Malignant glaucoma as a complication of intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 84: 712-713.
11. Iomdina EN (2000): Biomechanics of scleral eye shell in myopia: diagnostic of disturbances and its experimental correction. Moscow: Moscow Helmholtz R & D Institute for Eye Diseases 376.
12. Jaissle GB, Szurman P & Bartz-Schmidt KU (2004): [Ocular side effects and complications of intravitreal triamcinolone acetonide injection.] Ophthalmologe 101: 121-128.
13. Jonas JB (2005a): Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83: 645-663.
14. Jonas JB (2005b): Intravitreal use of tAiamcinolone acetonide: an experimental clinical procedure. Acta Ophthalmol Scand 83: 526-527.
15. Jonas JB, Degenring RF, Kreissig I, Friedemann T & Akkoyun I (2005): Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative non-randomized study. Eye 19: 163-170.
16. Jonas JB, Kreissig I & Degenring RF (2004b): Retinal complications of intravitreal injections of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol 242: 184-185.
17. Jonas JB, Kreissig I, Kamppeter B & Degenring RF (2004a): [Intravitreal triamcinolone acetonide for the treatment of intraocular oedematous and neovascular diseases.] Ophthalmologe 101: 113-120.
18. Michels S & Rosenfeld PJ (2005): [Treatment of neovascular age-related macular degeneration with ranibizumab/Lucentis. Klin Monatsbl Augenheilkd 222: 480-484.
19. Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA & Tsilimbaris MK (2005): Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci 46: 409-414.
20. Silver DM & Geyer O (2000): Pressure-volume relation for the living human eye. Curr Eye Res 20: 115-120.
21. Sivaprasad S, McCluskey P & Lightman S (2006): Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 84: 722-733.
22. Sorensen TL, Haamann P, Villumsen J & Larsen M (2005): Intravitreal triamcinolone for macular oedema: Efficacy in relation to aetiology. Acta Ophthalmol Scand 83: 67-70.
23. Spaide RF, Sorenson J & Maranan L (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517-1525.